255 related articles for article (PubMed ID: 26361417)
41. Current and future biomarkers in gastric cancer.
Abbas M; Faggian A; Sintali DN; Khan GJ; Naeem S; Shi M; Dingding C
Biomed Pharmacother; 2018 Jul; 103():1688-1700. PubMed ID: 29864959
[TBL] [Abstract][Full Text] [Related]
42. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
[TBL] [Abstract][Full Text] [Related]
43. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
44. ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer.
Maruo Y; Gochi A; Kaihara A; Shimamura H; Yamada T; Tanaka N; Orita K
Int J Cancer; 2002 Aug; 100(4):486-90. PubMed ID: 12115535
[TBL] [Abstract][Full Text] [Related]
45. Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.
Li H; Wang Z; Zhang W; Qian K; Xu W; Zhang S
Cancer Lett; 2016 Jan; 370(1):39-55. PubMed ID: 26458995
[TBL] [Abstract][Full Text] [Related]
46. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis.
Tsai CY; Wang CS; Tsai MM; Chi HC; Cheng WL; Tseng YH; Chen CY; Lin CD; Wu JI; Wang LH; Lin KH
Clin Cancer Res; 2014 May; 20(9):2276-88. PubMed ID: 24602839
[TBL] [Abstract][Full Text] [Related]
48. 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer.
Lin HL; Yang MH; Wu CW; Chen PM; Yang YP; Chu YR; Kao CL; Ku HH; Lo JF; Liou JP; Chi CW; Chiou SH
Int J Cancer; 2007 Dec; 121(11):2547-55. PubMed ID: 17680560
[TBL] [Abstract][Full Text] [Related]
49. Zipper-interacting protein kinase promotes epithelial-mesenchymal transition, invasion and metastasis through AKT and NF-kB signaling and is associated with metastasis and poor prognosis in gastric cancer patients.
Li J; Deng Z; Wang Z; Wang D; Zhang L; Su Q; Lai Y; Li B; Luo Z; Chen X; Chen Y; Huang X; Ma J; Wang W; Bi J; Guan X
Oncotarget; 2015 Apr; 6(10):8323-38. PubMed ID: 25831050
[TBL] [Abstract][Full Text] [Related]
50. High expression of cAMP-responsive element-binding protein 1 (CREB1) is associated with metastasis, tumor stage and poor outcome in gastric cancer.
Wang YW; Chen X; Gao JW; Zhang H; Ma RR; Gao ZH; Gao P
Oncotarget; 2015 Apr; 6(12):10646-57. PubMed ID: 25825983
[TBL] [Abstract][Full Text] [Related]
51. Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis.
Li X; Zhang Y; Cao S; Chen X; Lu Y; Jin H; Sun S; Chen B; Liu J; Ding J; Wu K; Fan D
Int J Cancer; 2009 Feb; 124(3):713-21. PubMed ID: 18972434
[TBL] [Abstract][Full Text] [Related]
52. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
53. Efficacy prediction of targeted therapy for gastric cancer: The current status (Review).
Feng W; Zhu X
Mol Med Rep; 2018 Aug; 18(2):1238-1246. PubMed ID: 29901092
[TBL] [Abstract][Full Text] [Related]
54. Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer.
Yang M; Huang CZ
World J Gastroenterol; 2015 Nov; 21(41):11673-9. PubMed ID: 26556994
[TBL] [Abstract][Full Text] [Related]
55. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
[TBL] [Abstract][Full Text] [Related]
56. CCR7 enhances TGF-β1-induced epithelial-mesenchymal transition and is associated with lymph node metastasis and poor overall survival in gastric cancer.
Ma H; Gao L; Li S; Qin J; Chen L; Liu X; Xu P; Wang F; Xiao H; Zhou S; Gao Q; Liu B; Sun Y; Liang C
Oncotarget; 2015 Sep; 6(27):24348-60. PubMed ID: 26176983
[TBL] [Abstract][Full Text] [Related]
57. Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis.
Cheng G; Li M; Wu J; Ji M; Fang C; Shi H; Zhu D; Chen L; Zhao J; Shi L; Xu B; Zheng X; Wu C; Jiang J
Int J Clin Exp Pathol; 2015; 8(8):9452-7. PubMed ID: 26464703
[TBL] [Abstract][Full Text] [Related]
58. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.
Matboli M; El-Nakeep S; Hossam N; Habieb A; Azazy AE; Ebrahim AE; Nagy Z; Abdel-Rahman O
World J Gastroenterol; 2016 Jul; 22(26):5896-908. PubMed ID: 27468184
[TBL] [Abstract][Full Text] [Related]
59. Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer.
Yan Y; Wang LF; Wang RF
World J Gastroenterol; 2015 Sep; 21(33):9717-26. PubMed ID: 26361418
[TBL] [Abstract][Full Text] [Related]
60. Gastric cancer: somatic genetics as a guide to therapy.
Zhang XY; Zhang PY
J Med Genet; 2017 May; 54(5):305-312. PubMed ID: 27609016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
